SEC Form 4 · accession 0001209191-18-050572
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lynn Dorsey Bleil
Director
Period of report
Sep 7, 2018
Accepted (ET)
Sep 11, 2018 · 7:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 7, 2018 | A | 9,600 | $0.00 | A | 9,600 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $12.50 | Sep 7, 2018 | A | 14,605 | A | — | Sep 7, 2028 | Common Stock | 14,605 | 14,605 | D |
Explanation of responses
- F1These restricted stock units (RSUs) vest in a series of installments. The first installment, which consists of 25% of the total aggregate number of RSUs vest on September 7, 2019 and the remaining RSUs vest in a series of thirty-five monthly installments beginning on October 1, 2019. Each restricted stock unit represents a right to receive one share of Amicus Therapeutics, Inc. common stock.
- F2These stock options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of stock options vest and become exercisable on September 7, 2019 and the remaining stock options vest and become exercisable in a series of thirty-five monthly installments beginning on October 1, 2019.